US$ 28.17
l carnitin hashimoto L-carnitin Clayman Thyroid Center Launches Inaugural
Description
Because adequate, well-controlled studies in pregnant individuals are lacking, use should be limited to circumstances in which the potential maternal benefit clearly outweighs theoretical fetal risk-such as treatment of documented systemic carnitine deficiency

Stark R, Reichenbach A, Andrews ZB

Effect of L-carnitine therapy on patients in maintenance hemodialysis: a systematic review and meta-analysis

Symptomatic treatment for PAD adds maximal risk factor modification, exercise, and, when indicated, invasive treatment using balloon angioplasty with or without stenting and bypass surgery together

Certain medical conditions and medications may interact with carnitine supplements, so medical supervision is important

Fallon B
